LIFELINE PHARMA AS
Organization
- CEO
- YZ
Yunlin Zhan1969
- Chairman of the board
- VM
Vegard Moltubakk1991
- Years since formation
- 30 years
- since Mar 12, 1995
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 100,000
- 1 share class
- Total number of shareholders
- 4
- 1 company, 3 persons
Financials
- Total operating income 2024
- 20,211,145
- NOK
- Annual total result 2024
- 327,643
- NOK
- Total equity 2024
- -1,327,637
- NOK
Last update: Sep 9, 2025
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
YZ 1969 | Managing Director/CEO | 18 % indirectly |
Board
| Name | Role | Shares |
|---|---|---|
VM 1991 | Chairman | - |
Others
| Name | Role | Shares |
|---|---|---|
| Auditor | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
EH 1996 | - | 50 % directly |
VZ 1985 | - | 20 % directly |
YZ 1969 | Managing Director/CEO | 18 % indirectly |
JX 1986 | - | 10 % directly |
Last update: Apr 13, 2023
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
EH 1996 | Ordinary shares | 50,000 | 50 % |
| Ordinary shares | 20,000 | 20 % | |
VZ 1985 | Ordinary shares | 20,000 | 20 % |
JX 1986 | Ordinary shares | 10,000 | 10 % |
Last update: Jun 2, 2025
Financials
in NOK
Summary
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total operating income | 20,211,145 | 18,734,606 | 18,095,726 | 30,689,514 |
Annual Total Result | 327,643 | -1,394,743 | 793,929 | -2,468,482 |
Total assets | 7,853,283 | 16,928,993 | 12,791,289 | 14,645,181 |
Total liabilities | 9,180,919 | 18,584,273 | 13,051,826 | 16,015,711 |
Total equity | -1,327,637 | -1,655,280 | -260,537 | -1,370,530 |
P&L
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total operating income | 20,211,145 | 18,734,606 | 18,095,726 | 30,689,514 |
Total operating costs | 19,836,745 | 19,414,473 | 17,043,425 | 32,983,417 |
Operating result | 374,399 | -679,867 | 1,052,301 | -2,293,904 |
Financial income/costs | -46,756 | -714,876 | -258,372 | -174,579 |
Profit before tax | 327,643 | -1,394,743 | 793,929 | -2,468,482 |
Total tax & extraordinary income/cost | 0 | 0 | 0 | 0 |
Annual Total Result | 327,643 | -1,394,743 | 793,929 | -2,468,482 |
Balance overview
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total fixed assets | 587,581 | 632,458 | 558,794 | 512,622 |
Total current assets | 7,265,702 | 16,296,535 | 12,232,495 | 14,132,559 |
Total assets | 7,853,283 | 16,928,993 | 12,791,289 | 14,645,181 |
Short term debt | 2,748,061 | 5,652,118 | 8,866,954 | 14,243,431 |
Long term debt | 6,432,858 | 12,932,155 | 4,184,872 | 1,772,279 |
Total liabilities | 9,180,919 | 18,584,273 | 13,051,826 | 16,015,711 |
Contributed capital | 100,000 | 100,000 | 100,000 | 100,000 |
Retained earnings | -1,427,637 | -1,755,280 | -360,537 | -1,470,530 |
Total equity | -1,327,637 | -1,655,280 | -260,537 | -1,370,530 |
Total equity and liabilities | 7,853,283 | 16,928,993 | 12,791,289 | 14,645,181 |
Classification
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises